Topic Modeling on Drug Review Norethindrone
0.582CvDALTA
Evaluation results
| Method | Links | ||
|---|---|---|---|
| DALTANumber of topics=102025.06 | 0.582 | 0.892 | |
| DALTANumber of topics=202025.06 | 0.571 | 0.8 | |
| Meta-CETMNumber of topics=202025.06 | 0.53 | 0.748 | |
| FastopicNumber of topics=102025.06 | 0.517 | 0.811 | |
| Meta-CETMNumber of topics=102025.06 | 0.493 | 0.845 | |
| FastopicNumber of topics=202025.06 | 0.49 | 0.948 | |
| ProdLDANumber of topics=202025.06 | 0.473 | 0.616 | |
| CTMNumber of topics=202025.06 | 0.47 | 0.694 | |
| CTMNumber of topics=102025.06 | 0.466 | 0.792 | |
| ECRTMNumber of topics=102025.06 | 0.459 | 0.632 | |
| LDANumber of topics=202025.06 | 0.444 | 0.372 | |
| LDANumber of topics=102025.06 | 0.439 | 0.42 | |
| ETMNumber of topics=102025.06 | 0.439 | 0.516 | |
| ProdLDANumber of topics=102025.06 | 0.437 | 0.796 | |
| ETMNumber of topics=202025.06 | 0.426 | 0.304 | |
| ECRTMNumber of topics=202025.06 | 0.41 | 0.86 | |
| DeTimeNumber of topics=102025.06 | 0.355 | 0.672 | |
| DeTimeNumber of topics=202025.06 | 0.341 | 0.652 |